CD1-MR1 2015* , ,
Presentations this author is a contributor to:
Synthetic glycolipid-peptide conjugate vaccines utilise NKT cell help in vivo for improved CD8+ T cell immune responses (#52)
6:56 PM
Taryn Osmond
Rapid Fire Talks II
A phase I dose escalation trial of immunisation with autologous dendritic cells pulsed with NY-ESO-1 peptide and α-galactosylceramide in patients with high-risk surgically resected stage II, III or IV melanoma (#100)
4:00 PM
Olivier Gasser
Poster Listing